Answers are grounded in this paper and cite their sources.
Distal limb wounds in horses account for more than 60% of all wounds. This study described the clinical effect of mesenchymal stem cell-derived microvesicles (MVs) on healing of equine distal limb chronic wounds. Twelve Arabian horses with distal limb granulating wounds (Group I, n=6) or ulcerated wounds (Group II, n=6) were treated surgically either by excision of the granulating masses or debridement of ulcers. In group I, the horses were divided randomly into two subgroups (3 horses each); subgroup 1 was given two doses of topical and subcutaneous injection of MVs after surgery. Subgroup 2 (control) was treated only by surgery. Group II was divided randomly into two equal subgroups; subgroup 1 was given one dose of topical and subcutaneous injection of MVs after surgery and subgroup 2 was treated by debridement (control). Healing progression was documented using digimizer image analysis software and data were statistically analyzed. The mean areas of the granulating and ulcerating wounds were 81.71±3.25 cm2 and 18.91±1.78 cm2, respectively. In group I, complete wound healing was achieved on days 70±3.5 and 100±4.32 in subgroups 1 and 2, respectively. However, complete wound healing was achieved in group II on days 27±2.3 and 41±3.1 in subgroups 1 and 2, respectively. There were statistically significant differences in wound area reduction between the two subgroups in both groups (P< .05). In conclusion, this preliminary study indicated that topical and subcutaneous injection of MVs after surgical interferences may enhance healing of the chronic wounds in distal limbs of horses.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: